Melanoma Research

Published by: Lippincott Williams & Wilkins  

People

  1. Berwick
    Berwick
  2. Chapman
    Chapman
  3. Coit
    Coit
  4. Bartido
    Bartido
  5. Brady
    Brady
  6. Busam
    Busam
  7. Chen
    Chen
  8. Coplan
    Coplan
  9. Gerald
    Gerald
  10. Houghton
    Houghton

Groups

  1. Melanoma Disease Management Team (4)
  2. Department of Medicine (3)
  3. Melanoma and Immunotherapeutics Service (3)
  4. Solid Tumor Oncology Division (3)
  5. Surgery (3)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  7. Survivorship Research (2)
  8. GSK Faculty (1)
  9. Immunology Program Faculty (1)
  10. Sloan Kettering Institute Faculty (1)
Search Within
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (10)
Groups
  1. Melanoma Disease Management Team (4)
  2. Department of Medicine (3)
  3. Melanoma and Immunotherapeutics Service (3)
  4. Solid Tumor Oncology Division (3)
  5. Surgery (3)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)

More Groups

People
  1. Daniel Coit (2)
  2. Marianne Berwick (2)
  3. Paul Chapman (2)
  4. Achim Jungbluth (1)
  5. Alan Houghton (1)
  6. David Klimstra (1)

More People

Years
  1. 2016 (3)
  2. 1997 (7)
Publishers
  1. Lippincott Williams & Wilkins (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of key prognostic factors on long-term overall survival in BRAF(V600)-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study
    Meeting Abstract

    Hauschild, A.; Chapman, P. B.; Robert, C.; Larkin, J.; Haanen, J. B.; Ribas, A.; Hogg, D.; Hamid, O.; Ascierto, P. A.; Testori, A.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • TERT promoter mutations in patients with BRAF(V600)-mutated melanoma treated with vemurafenib or cobimetinib combined with vemurafenib
    Meeting Abstract

    Wongchenko, M. J.; Larkin, J.; McArthur, G. A.; Ribas, A.; Dreno, B.; Chapman, P. B.; Maio, M.; Garbe, C.; Robert, C.; Lu, W.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • Efficacy and quality of life outcomes in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase 3 trial (CheckMate 067)
    Meeting Abstract

    Schadendorf, D.; Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; Taylor, F.; Sabater, J.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • Follow-up of the melanoma patient
    Meeting Abstract

    Coit, D. G.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • The detection of micrometastases in melanoma sentinel nodes by step-sectioning and immunohistochemical staining
    Meeting Abstract

    Bieligk, S. C.; Klimstra, D. S.; Rosai, J.; Coit, D. G.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • Genetic cancer vaccines
    Meeting Abstract

    Lewis, J. J.; Wang, S.; Bartido, S.; Weber, L. W.; Ross, H.; Houghton, A. N.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • A103 and T311: Two new monoclonal antibodies against the Melan-A (MART-1) and tyrosinase antigens for use on formalin-fixed paraffin-embedded tissues
    Meeting Abstract

    Jungbluth, A. A.; Chen, Y. T.; Stockert, E.; Iversen, K.; Coplan, K.; Tsang, S.; Busam, K.; Gerald, W.; Old, L. J.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • Cytokine response of CD4+ T cells responding to HLA class II+ melanoma
    Meeting Abstract

    Brady, M.; Lee, F.; Ree, S.; Eckles, D.; Lee, J.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • A comparison of risk factors for in situ melanoma and invasive melanoma
    Meeting Abstract

    Berwick, M.; Fine, J. A.; Barnhill, R. L.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • Changes in the incidence of melanoma by Breslow depth in Connecticut between 1974-1976 and 1985-87
    Meeting Abstract

    Berwick, M.; Fine, J. A.; Sagebiel, R.; O'Neill, D.; Gross, E.; Shapiro, P.; Hukill, P.; Barnhill, R. L.
    Melanoma Research (1997)

    Fulltext@MSK | Save

    • Melanoma Research – authorized name for:

    Name ISSN / ISBN Publisher
    Melanoma Research 09608931 Lippincott Williams & Wilkins
    Melanoma Research 09608931 Rapid Communications of Oxford Ltd
    Melanoma Research 0960-8931 Wolters Kluwer Health, Inc
    Melanoma Research 0960-8931 Lippincott Williams & Wilkins
    Melanoma Research 0960-8931 Unknown
    Melanoma research 14735636 Unknown
    Melanoma Research 09608931 Lippincott Williams & Wilkins
    Melanoma Research 09608931 Wolters Kluwer Health | Lippincott Williams & Wilkins
    Melanoma research 14735636 Wolters Kluwer Health, Inc
    Melanoma Research 0960-8931 Lippincott Williams & Wilkins
    Melanoma Research 0960-8931 Wolters Kluwer Health | Lippincott Williams & Wilkins
    Melanoma Research 0960-8931 Rapid Science Publishers
    Melanoma Research 0960-8931 Lippincott Williams & Wilkins
    Melanoma Research 1473-5636 Lippincott Williams & Wilkins
    Melanoma Research 09608931 Unknown
    Melanoma Research 0960-8931 Ovid Technologies, Inc.
    Melanoma Research 09608931 Wolters Kluwer Health | Lippincott Williams & Wilkins
    Melanoma Research 09608931 Lippincott Williams & Wilkins